<div class="row">
    <div class="col-md-10 col-md-offset-1">
        <div class="panel panel-primary">
            <div class="panel-heading">
                <h2 class="panel-title">

                </h2>
            </div>
            <div class="panel-body" style="font-size: 16px;">
                <ul>
                    <li>
                        Solubility measurement, model evaluation and thermodynamic analysis of rivaroxaban polymorphs in organic solvents
                    </li>
                </ul>
            </div>
        </div>
    </div>
</div>
<div class="row">
    <div class="col-md-10 col-md-offset-1">
        <div class="panel panel-info">
            <div class="panel-heading">
                <h2 class="panel-title">Data</h2>
            </div>
            <div class="list-group">
                [{&#x27;id&#x27;: 114816, &#x27;desc&#x27;: &#x27;1 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Triple point temperature, &lt;b&gt;system:&lt;/b&gt; (S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide&#x27;}, {&#x27;id&#x27;: 114817, &#x27;desc&#x27;: &#x27;1 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Molar enthalpy of transition or fusion, &lt;b&gt;system:&lt;/b&gt; (S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide&#x27;}, {&#x27;id&#x27;: 114818, &#x27;desc&#x27;: &#x27;1 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mass density, &lt;b&gt;system:&lt;/b&gt; (S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide&#x27;}, {&#x27;id&#x27;: 114819, &#x27;desc&#x27;: &#x27;1 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mass density, &lt;b&gt;system:&lt;/b&gt; (S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide&#x27;}, {&#x27;id&#x27;: 114820, &#x27;desc&#x27;: &#x27;1 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mass density, &lt;b&gt;system:&lt;/b&gt; (S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide&#x27;}, {&#x27;id&#x27;: 114821, &#x27;desc&#x27;: &#x27;1 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mass density, &lt;b&gt;system:&lt;/b&gt; (S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide&#x27;}, {&#x27;id&#x27;: 114822, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; acetonitrile + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114823, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; acetonitrile + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114824, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; methyl ethanoate + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114825, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; methyl ethanoate + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114826, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; 1,4-dioxane + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114827, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; 1,4-dioxane + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114828, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; acetone + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114829, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; acetone + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114830, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; butanone + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114831, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; butanone + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114832, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; pentan-3-one + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114833, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; pentan-3-one + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114834, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; 2-hexanone + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114835, &#x27;desc&#x27;: &#x27;10 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; 2-hexanone + Rivaroxaban&#x27;}, {&#x27;id&#x27;: 114836, &#x27;desc&#x27;: &#x27;1 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; water + (S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide&#x27;}, {&#x27;id&#x27;: 114837, &#x27;desc&#x27;: &#x27;1 datapoints in 1 series, &lt;b&gt;quantities:&lt;/b&gt; Mole fraction, &lt;b&gt;system:&lt;/b&gt; water + (S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide&#x27;}]

				<a href="/datasets/view/temp" class="list-group-item list-group-item-small">temp</a>"
			</div>
        </div>
    </div>
</div>